ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Ivabradine Fails to Prevent Post-Surgery MINS 09/01/25"
Episode Synopsis
Welcome to Cardiology Today – Episode recorded on September 01, 2025. Your source for the latest cardiology research findings from top medical journals.
Listen to This Episode
Your browser does not support the audio element.
Episode Summary
This episode covers 1 recent cardiology research articles published in leading journals including NEJM, JACC, Circulation, European Heart Journal, and Nature Reviews Cardiology.
Featured Research Articles
Article 1: Ivabradine in Patients Undergoing Noncardiac Surgery: a Randomized Controlled Trial.
Journal: Circulation
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40884771
Summary: This randomized controlled trial investigated ivabradine, a selective heart rate lowering agent, in patients undergoing noncardiac surgery to prevent myocardial injury after noncardiac surgery. The study found no significant reduction in myocardial injury after noncardiac surgery with ivabradine compared to placebo in patients aged 45 years or older with or at risk of atherosclerotic disease. These findings do not support routine use of ivabradine for prevention of myocardial injury after noncardiac surgery.
Full Episode Transcript
Today’s date is September 01, 2025. Welcome to Cardiology Today. Here are the latest research findings.
Article number one. Ivabradine in Patients Undergoing Noncardiac Surgery: a Randomized Controlled Trial. This randomized controlled trial investigated ivabradine, a selective heart rate lowering agent, in patients undergoing noncardiac surgery to prevent myocardial injury after noncardiac surgery. The study found no significant reduction in myocardial injury after noncardiac surgery with ivabradine compared to placebo in patients aged 45 years or older with or at risk of atherosclerotic disease. These findings do not support routine use of ivabradine for prevention of myocardial injury after noncardiac surgery.
Thank you for listening to Cardiology Today.
Keywords
Medical Topics: Cardiology, Cardiovascular Medicine, Heart Disease, Clinical Research, Medical Education, Evidence-Based Medicine
Journals: New England Journal of Medicine (NEJM), Journal of American College of Cardiology (JACC), Circulation, European Heart Journal, Nature Reviews Cardiology
About Cardiology Today
Cardiology Today provides concise, professional summaries of cutting-edge cardiovascular research for healthcare professionals, medical students, and cardiology enthusiasts. Each episode features the latest findings from top-tier medical journals, delivered in an accessible format perfect for staying current with advances in cardiac care.
Subscribe to stay updated with the latest cardiology research • Share with colleagues • Follow for more medical contentThe post Ivabradine Fails to Prevent Post-Surgery MINS 09/01/25 first appeared on Cardiology Today.
Listen to This Episode
Your browser does not support the audio element.
Episode Summary
This episode covers 1 recent cardiology research articles published in leading journals including NEJM, JACC, Circulation, European Heart Journal, and Nature Reviews Cardiology.
Featured Research Articles
Article 1: Ivabradine in Patients Undergoing Noncardiac Surgery: a Randomized Controlled Trial.
Journal: Circulation
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40884771
Summary: This randomized controlled trial investigated ivabradine, a selective heart rate lowering agent, in patients undergoing noncardiac surgery to prevent myocardial injury after noncardiac surgery. The study found no significant reduction in myocardial injury after noncardiac surgery with ivabradine compared to placebo in patients aged 45 years or older with or at risk of atherosclerotic disease. These findings do not support routine use of ivabradine for prevention of myocardial injury after noncardiac surgery.
Full Episode Transcript
Today’s date is September 01, 2025. Welcome to Cardiology Today. Here are the latest research findings.
Article number one. Ivabradine in Patients Undergoing Noncardiac Surgery: a Randomized Controlled Trial. This randomized controlled trial investigated ivabradine, a selective heart rate lowering agent, in patients undergoing noncardiac surgery to prevent myocardial injury after noncardiac surgery. The study found no significant reduction in myocardial injury after noncardiac surgery with ivabradine compared to placebo in patients aged 45 years or older with or at risk of atherosclerotic disease. These findings do not support routine use of ivabradine for prevention of myocardial injury after noncardiac surgery.
Thank you for listening to Cardiology Today.
Keywords
Medical Topics: Cardiology, Cardiovascular Medicine, Heart Disease, Clinical Research, Medical Education, Evidence-Based Medicine
Journals: New England Journal of Medicine (NEJM), Journal of American College of Cardiology (JACC), Circulation, European Heart Journal, Nature Reviews Cardiology
About Cardiology Today
Cardiology Today provides concise, professional summaries of cutting-edge cardiovascular research for healthcare professionals, medical students, and cardiology enthusiasts. Each episode features the latest findings from top-tier medical journals, delivered in an accessible format perfect for staying current with advances in cardiac care.
Subscribe to stay updated with the latest cardiology research • Share with colleagues • Follow for more medical contentThe post Ivabradine Fails to Prevent Post-Surgery MINS 09/01/25 first appeared on Cardiology Today.
More episodes of the podcast Cardiology Today
Nup35 Controls Heart Remodeling 10/28/25
28/10/2025
In God we trust